Ziprasidone augmentation for anxious depression.

about

The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review.

P2860

Q38861612-E8118ABC-C9F4-4DBF-AC07-BE8EA540915B

P2860

Ziprasidone augmentation for anxious depression.

Item

http://www.wikidata.org/entity/Q42593330

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ziprasidone augmentation for anxious depression.

@en

Ziprasidone augmentation for anxious depression.

@nl

type

Item

label

Ziprasidone augmentation for anxious depression.

@en

Ziprasidone augmentation for anxious depression.

@nl

prefLabel

Ziprasidone augmentation for anxious depression.

@en

Ziprasidone augmentation for anxious depression.

@nl

P1476

Ziprasidone augmentation for anxious depression.

@en

P2093

Dawn F Ionescu

http://www.w3.org/2001/XMLSchema#string

George I Papakostas

http://www.w3.org/2001/XMLSchema#string

Kathryn H Meade

http://www.w3.org/2001/XMLSchema#string

Lee Baer

http://www.w3.org/2001/XMLSchema#string

Maurizio Fava

http://www.w3.org/2001/XMLSchema#string

Richard C Shelton

http://www.w3.org/2001/XMLSchema#string

P2860

Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes

The assessment of anxiety states by rating

Pharmacologic treatment of dimensional anxious depression: a review

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials.

Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.

Cognitive therapy for anxious depression in STAR(*) D: what have we learned?

Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study.

Assessing anxious features in depressed outpatients.

Defining anxious depression: a review of the literature.

Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project.

P304

341-346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/YIC.0000000000000133

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michaela B Swee

P577

2016-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27306192

http://www.w3.org/2001/XMLSchema#string

P932

5039050

http://www.w3.org/2001/XMLSchema#string

Ziprasidone augmentation for anxious depression.

about

P2860

P2860

Ziprasidone augmentation for anxious depression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932